When it comes to Ebola outbreaks, it’s not often we have two pieces of good news in one week. First, we heard there’s new funding of up to US$62 million to fast-track the development of vaccine candidates against the type of virus circulating in the Democratic Republic of the Congo (DRC) and neighboring Uganda.
Continue Reading this article here
